Salmonella enterica subsp. enterica

Salmonella enterica
Salmonella Typhimurium colonies on a Hektoen enteric agar plate
Scientific classification
Kingdom:	Bacteria
Phylum:	Proteobacteria
Class:	Gammaproteobacteria
Order:	Enterobacteriales
Family:	Enterobacteriaceae
Genus:	Salmonella
Species:	S. enterica
Subspecies:	S. e. subsp. enterica
Trinomial name
Salmonella enterica subsp. enterica
Serovar
Salmonella Choleraesuis Salmonella Dublin Salmonella Enteritidis Salmonella Heidelberg Salmonella Paratyphi Salmonella Typhi Salmonella Typhimurium

Salmonella enterica subsp. enterica is a subspecies of Salmonella enterica, the rod-shaped, flagellated, aerobic, Gram-negative bacterium. Many of the pathogenic serovars of the S. enterica species are in this subspecies, including that responsible for typhoid.^[1]

Serovars

S. enterica subsp. enterica contains a large number of serovars which can infect a broad range of vertebrate hosts. The individual members range from being highly host-adapted (only able to infect a narrow range of species) to displaying a broad host range. A number of techniques are currently used to differentiate between serotypes. These include looking for the presence or absence of antigens, phage typing, molecular fingerprinting and biotyping, where serovars are differentiated by which nutrients they are able to ferment. A possible factor in determining the host range of particular serovars is phage-mediated acquisition of a small number of genetic elements that enable infection of a particular host.^[2] It is further postulated that serovars which infect a narrow range of species have diverged from ancestors with a broad host range, and have since specialised and lost the ability to infect some hosts.^[3]

A selection of serovars, with known hosts listed. Since there are more than 2500 serovars of Salmonella enterica subsp. enterica, this list is incomplete.

A study of data from 37 countries collected between 2001 and 2007 found that the most common serovars of Salmonella isolated from human cases was enteritidis, found in an average of 43.5% of cases, followed by Typhimurium (17.1% of cases), Newport (3.5%), Infantis (1.8%), Virchow (1.5%), Hadar (1.5%), and Agona (0.8%).^[5]

One strain of Salmonella that has recently been emerging in the United States is Salmonella javiana. "An outbreak occurred in 2002, there were 141 cases that occurred among the participants of the U.S. Transplant Games. Out of the 141 cases, most of the cases were either transplant recipients (34%) or people receiving immunosuppressive therapy (32%)". There is an increasing number of Salmonella serotypes that are multidrug resistant (MDR), which was identified by the CDC's National Antimicrobial Resistance Monitoring System.^[6] "Salmonella javiana causes 4% of nontyphodial Salmonella infections in the United States each year."^[7]

Metabolism

Genetic evidence suggests that the serovars can be divided into two groups – one which causes enteric infection and has a broad repertoire of metabolic capabilities, and one which usually causes invasive infection, often in a narrow range of hosts, and shows degradation of anaerobic metabolic pathways. It is thought that these metabolic capabilities are important for obtaining nutrients in the challenging and nutrient-limited inflamed gut environment.^[8]

Nomenclature

The serovars can be designated fully or in a shortened form.^[9] The short form lists the genus, Salmonella, which is followed by the capitalized and non-italicized serovar. The full designation for Salmonella Typhi is Salmonella enterica subsp. enterica, serovar Typhi. Each serovar can have many strains, as well, which allows for a rapid increase in the total number of antigenically variable bacteria.^[10]

Epidemiology

Invasive strains of non-typhoidal salmonella, such as Salmonella Typhimurium ST313 have recently been labelled as emerging diseases in Africa. Key host immune deficiencies associated with HIV, malaria and malnutrition have contributed to a wide spread of this disease and the need to use expensive antimicrobial drugs in the poorest health services in the world.^[11]

References